AliquantumRx

Business Data, Corporate Office and Headquarter Address

About

AliquantumRx is Drug Discovery in United States that focus on developer business. Founded in 2016. They cover business area such as developer, liver-stage malaria, new use, several disease, significant potential, valuable new treatment, people, clinical and harmful illness.

Business Type

Drug Discovery

Country

United States

Founded

2016
( 8 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

1812 Ashland Avenue
Suite 100
Baltimore, MD 21205
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerliver-stage malarianew useseveral diseasesignificant potentialvaluable new treatmentpeopleclinical and harmful illness

* We use standard office opening hours in near AliquantumRx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

AliquantumRx Frequently Asked Questions

What or who is AliquantumRx?

AliquantumRx is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), AliquantumRx business is focusing on Developer.

Where is AliquantumRx headquarter and corporate office address?

AliquantumRx headquarter office and corporate office address is located in 1812 Ashland Avenue Suite 100 Baltimore, MD 21205 United States.

Where is AliquantumRx country origins?

AliquantumRx was founded in United States.

What is Developer business focus on?

In 2024, AliquantumRx is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with AliquantumRx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.